Skip To Main Content

Actualización normativa

En un entorno en constante cambio como el sistema de salud, es fundamental mantenerse al día con las nuevas normativas que afectan tanto a profesionales como a pacientes. En este espacio encontrará las leyes, decretos, resoluciones y acuerdos relacionados con el sistema de salud dinámico y en evolución.

También encontrará resúmenes, análisis y todo lo relacionado con la más reciente normatividad, para comprender el posible impacto de los cambios hacia los diferentes actores del sistema.

Ordenar por
ERS 2025 Congress Highlights: Innovations in Respiratory Care and Biologics

ERS 2025 Congress Highlights: Innovations in Respiratory Care and Biologics

Explore key clinical insights and trial data from ERS 2025, including breakthroughs in biologics for asthma and COPD, pediatric asthma management, and AI-enabled respiratory innovation. Curated for healthcare professionals.

ERS 2025 Congress Highlights: Innovations in Respiratory Care and Biologics

ERS 2025 Congress Highlights: Innovations in Respiratory Care and Biologics

Explore key clinical insights and trial data from ERS 2025, including breakthroughs in biologics for asthma and COPD, pediatric asthma management, and AI-enabled respiratory innovation. Curated for healthcare professionals.

Kongres ESC 2025 - dr. Jose Fernandes Tunon dzieli się spostrzeżeniami na temat zmian w wytycznych dotyczących dyslipidemii. Zobacz teraz!

Kongres ESC 2025 - dr. Jose Fernandes Tunon dzieli się spostrzeżeniami na temat zmian w wytycznych dotyczących dyslipidemii. Zobacz teraz!

Tiêm Chủng Trong Thai Kỳ: Yếu Tố Quan Trọng Trong Chăm Sóc Sức Khỏe Thai Sản

Tiêm Chủng Trong Thai Kỳ: Yếu Tố Quan Trọng Trong Chăm Sóc Sức Khỏe Thai Sản

Discover the PulmoRounds: Where Respiratory Expertise Meets Clinical Practice

Discover the PulmoRounds: Where Respiratory Expertise Meets Clinical Practice

IL-4 and IL-13: the key and central drivers of type 2 inflammation<sup>1-2,6-7</sup>

IL-4 and IL-13: the key and central drivers of type 2 inflammation

Clinical Indicators of COPD: A GOLD Guidelines Review

Clinical Indicators of COPD: A GOLD Guidelines Review

This video highlights the key insights from the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, presenting a clear, structured, and evidence-based approach to the diagnosis, assessment, and management of COPD.

Clinical Indicators of COPD: A GOLD Guidelines Review

Clinical Indicators of COPD: A GOLD Guidelines Review

This video highlights the key insights from the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, presenting a clear, structured, and evidence-based approach to the diagnosis, assessment, and management of COPD.

Clinical Indicators of COPD: A GOLD Guidelines Review

Clinical Indicators of COPD: A GOLD Guidelines Review

This video highlights the key insights from the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, presenting a clear, structured, and evidence-based approach to the diagnosis, assessment, and management of COPD.

Clinical Indicators of COPD: A GOLD Guidelines Review

Clinical Indicators of COPD: A GOLD Guidelines Review

This video highlights the key insights from the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, presenting a clear, structured, and evidence-based approach to the diagnosis, assessment, and management of COPD.

The Cumulative Disease Burden of AD in Adult Patients

The Cumulative Disease Burden of AD in Adult Patients

This video highlights that the burden of atopic dermatitis in adults extends beyond skin symptoms, encompassing a broad spectrum of atopic and non-atopic comorbidities. These related conditions have a major impact on patient care, clinical decisions, and overall quality of life.

Long Term Impact of AD and the Potential benefits of early intervention

Long Term Impact of AD and the Potential benefits of early intervention

This video explores the long-term, multi-dimensional burden of moderate-to-severe atopic dermatitis, highlighting its impact beyond the skin. It emphasizes the importance of early intervention targeting type 2 inflammation to alter the disease course and prevent long-term comorbidities.

Material diseñado por o para Sanofi Aventis de Colombia S.A., con fines educativos y dirigido a profesionales de la salud y personal administrativo del sector salud. Es estrictamente prohibido compartir este material con terceros.

Mayor información a disposición en el Departamento Médico:

En Colombia:

Sanofi-Aventis de Colombia S.A. Transversal 23 N° 97-73 - Edificio City Business. Piso 8. Bogotá D.C. Teléfono: 621 4400 - Fax: 744 4237

infomedica.colombia@sanofi.com

En Bolivia, Centro América y Caribe:

Sanofi-Aventis de Panamá S.A. Torre Evolution, piso 26, Calle 50 y Av. Aquilino de la Guardia Obarrio- Cuidad de Panamá, República de Panamá Telf.: (507) 382-9500. infomed.pac@sanofi.com

Sitio web: http://www.sanofi.com.pa/l/pa/sp/index.jsp

 

MAT-CO-2400825 V1.0 03/2024